ERBB2 and breast cancer: Endobronchial ultrasound-guided transbronchial needle aspiration of the mediastinum lymph node confirmed the recurrence of ER-positive, PR-negative, and HER2 2+/fluorescence in situ hybridization-negative breast cancer (Figures 1C–G).